Andres Maldonado
Stock Analyst at HC Wainwright & Co.
(3.82)
# 675
Out of 5,106 analysts
80
Total ratings
46.15%
Success rate
11.34%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Andres Maldonado
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IBRX ImmunityBio | Reiterates: Buy | $8 | $2.10 | +280.95% | 4 | Jun 4, 2025 | |
| AURA Aura Biosciences | Assumes: Buy | $22 | $6.04 | +264.24% | 1 | May 28, 2025 | |
| ZNTL Zentalis Pharmaceuticals | Reiterates: Buy | $10 | $1.35 | +640.74% | 1 | May 15, 2025 | |
| CRBP Corbus Pharmaceuticals Holdings | Maintains: Buy | $50 → $40 | $8.19 | +388.40% | 2 | May 7, 2025 | |
| TCRX TScan Therapeutics | Maintains: Buy | $15 → $10 | $0.91 | +998.06% | 1 | May 7, 2025 | |
| ERAS Erasca | Reiterates: Buy | $6 | $3.39 | +76.99% | 10 | Apr 30, 2025 | |
| FHTX Foghorn Therapeutics | Reiterates: Buy | $13 | $5.55 | +134.23% | 1 | Apr 30, 2025 | |
| STRO Sutro Biopharma | Reiterates: Neutral | $20 | $10.38 | +92.68% | 1 | Apr 29, 2025 | |
| TARA Protara Therapeutics | Reiterates: Buy | $23 | $5.37 | +328.31% | 1 | Apr 28, 2025 | |
| CGON CG Oncology | Reiterates: Buy | $75 | $40.05 | +87.27% | 13 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $36 | $9.63 | +273.83% | 14 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $0.63 | +2,285.88% | 16 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $9.22 | +171.15% | 2 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $50 | $45.89 | +8.96% | 13 | Nov 26, 2024 |
ImmunityBio
Jun 4, 2025
Reiterates: Buy
Price Target: $8
Current: $2.10
Upside: +280.95%
Aura Biosciences
May 28, 2025
Assumes: Buy
Price Target: $22
Current: $6.04
Upside: +264.24%
Zentalis Pharmaceuticals
May 15, 2025
Reiterates: Buy
Price Target: $10
Current: $1.35
Upside: +640.74%
Corbus Pharmaceuticals Holdings
May 7, 2025
Maintains: Buy
Price Target: $50 → $40
Current: $8.19
Upside: +388.40%
TScan Therapeutics
May 7, 2025
Maintains: Buy
Price Target: $15 → $10
Current: $0.91
Upside: +998.06%
Erasca
Apr 30, 2025
Reiterates: Buy
Price Target: $6
Current: $3.39
Upside: +76.99%
Foghorn Therapeutics
Apr 30, 2025
Reiterates: Buy
Price Target: $13
Current: $5.55
Upside: +134.23%
Sutro Biopharma
Apr 29, 2025
Reiterates: Neutral
Price Target: $20
Current: $10.38
Upside: +92.68%
Protara Therapeutics
Apr 28, 2025
Reiterates: Buy
Price Target: $23
Current: $5.37
Upside: +328.31%
CG Oncology
Apr 28, 2025
Reiterates: Buy
Price Target: $75
Current: $40.05
Upside: +87.27%
Apr 3, 2025
Reiterates: Buy
Price Target: $36
Current: $9.63
Upside: +273.83%
Mar 12, 2025
Reiterates: Buy
Price Target: $15
Current: $0.63
Upside: +2,285.88%
Mar 11, 2025
Reiterates: Buy
Price Target: $25
Current: $9.22
Upside: +171.15%
Nov 26, 2024
Maintains: Buy
Price Target: $40 → $50
Current: $45.89
Upside: +8.96%